These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 27270320

  • 1. PIK3C2A mRNA functions as a miR-124 sponge to facilitate CD151 expression and enhance malignancy of hepatocellular carcinoma cells.
    Liu T, Zu CH, Wang SS, Song HL, Wang ZL, Xu XN, Liu HS, Wang YL, Shen ZY.
    Oncotarget; 2016 Jul 12; 7(28):43376-43389. PubMed ID: 27270320
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Downregulation of circDYNC1H1 exhibits inhibitor effect on cell proliferation and migration in hepatocellular carcinoma through miR-140-5p.
    Wang ZY, Zhu Z, Wang HF, Qin B, Liu J, Yao XH, Li WC, Chen KS.
    J Cell Physiol; 2019 Aug 12; 234(10):17775-17785. PubMed ID: 30864145
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MiR-3174 promotes proliferation and inhibits apoptosis by targeting FOXO1 in hepatocellular carcinoma.
    Wang Q, Yang X, Zhou X, Wu B, Zhu D, Jia W, Chu J, Wang J, Wu J, Kong L.
    Biochem Biophys Res Commun; 2020 Jun 11; 526(4):889-897. PubMed ID: 32279994
    [Abstract] [Full Text] [Related]

  • 8. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
    Zhu Q, Gong L, Wang J, Tu Q, Yao L, Zhang JR, Han XJ, Zhu SJ, Wang SM, Li YH, Zhang W.
    BMC Cancer; 2016 Oct 18; 16(1):806. PubMed ID: 27756250
    [Abstract] [Full Text] [Related]

  • 9. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma.
    Lv J, Kong Y, Gao Z, Liu Y, Zhu P, Yu Z.
    Int J Biochem Cell Biol; 2018 Aug 18; 101():19-28. PubMed ID: 29791864
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A, Tang H.
    Oncotarget; 2015 Nov 10; 6(35):38093-106. PubMed ID: 26497554
    [Abstract] [Full Text] [Related]

  • 12. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
    Buurman R, Gürlevik E, Schäffer V, Eilers M, Sandbothe M, Kreipe H, Wilkens L, Schlegelberger B, Kühnel F, Skawran B.
    Gastroenterology; 2012 Sep 10; 143(3):811-820.e15. PubMed ID: 22641068
    [Abstract] [Full Text] [Related]

  • 13. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
    Zhang J, Luo N, Luo Y, Peng Z, Zhang T, Li S.
    Int J Oncol; 2012 Mar 10; 40(3):747-56. PubMed ID: 22025269
    [Abstract] [Full Text] [Related]

  • 14. miR-613 inhibits the growth and invasiveness of human hepatocellular carcinoma via targeting DCLK1.
    Wang W, Zhang H, Wang L, Zhang S, Tang M.
    Biochem Biophys Res Commun; 2016 May 13; 473(4):987-992. PubMed ID: 27049311
    [Abstract] [Full Text] [Related]

  • 15. miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma.
    Shyu YC, Lee TL, Lu MJ, Chen JR, Chien RN, Chen HY, Lin JF, Tsou AP, Chen YH, Hsieh CW, Huang TS.
    J Transl Med; 2016 Jul 02; 14(1):200. PubMed ID: 27370270
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin JS.
    Oncogene; 2012 Jul 12; 31(28):3357-69. PubMed ID: 22056881
    [Abstract] [Full Text] [Related]

  • 17. Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells.
    He J, Zhao K, Zheng L, Xu Z, Gong W, Chen S, Shen X, Huang G, Gao M, Zeng Y, Zhang Y, He F.
    Mol Cancer; 2015 Aug 25; 14():163. PubMed ID: 26302777
    [Abstract] [Full Text] [Related]

  • 18. ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma.
    Jang JY, Lee YS, Jeon YK, Lee K, Jang JJ, Kim CW.
    Exp Mol Med; 2013 Jan 10; 45(1):e3. PubMed ID: 23306701
    [Abstract] [Full Text] [Related]

  • 19. MiR-103 regulates hepatocellular carcinoma growth by targeting AKAP12.
    Xia W, Ni J, Zhuang J, Qian L, Wang P, Wang J.
    Int J Biochem Cell Biol; 2016 Feb 10; 71():1-11. PubMed ID: 26646106
    [Abstract] [Full Text] [Related]

  • 20. Anti-invasion and anti-migration effects of miR-199a-3p in hepatocellular carcinoma are due in part to targeting CD151.
    Kim JH, Badawi M, Park JK, Jiang J, Mo X, Roberts LR, Schmittgen TD.
    Int J Oncol; 2016 Nov 10; 49(5):2037-2045. PubMed ID: 27599545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.